Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Embla Medical hf Director's Dealing 2016

May 12, 2016

8210_rns_2016-05-12_c06e59d5-d99b-4038-8f43-90b4af9b998e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

NASDAQ OMX

FJÄRMÁLAPFIRLITID

THE FINANCIAL SUPERVISORY AUTHORITY, ICELAND

Announcement Össur hf. No. 48/2016

Auōkenni útgefanda/Trade ticker: OSSR

Nafn útgefanda/Issuer: Össur hf.

Dagsetning tilkynningar/Date of announcement: 12 May 2016

Nafn fruminnerja/Name primary insider: Jos van Poorten

Tengsl fruminnerja við útgefanda/Insider's relation with the issuer: Managing Director of EMEA

Dagsetning viðskipta/Date of transaction: 12 May 2016

Tímasetning viðskipta/Time of transaction: 17:30 CET

Tegund fjármálagernings/Type of financial instrument: Equities

Kaup eða sala/Buy or Sell: Sell

Fjöldi hluta/Number of shares: 36,207

Verð pr. Hlut/Price per share: DKK 25.93

Fjöldi hluta í eigu fruminnerja eftir viðskipti/Primary insider's holdings after the transaction: 1,419

Fjöldi hluta sem fruminnerji á kauprétt að/Primary insider's option holdings after the transaction: 363,793

Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties' holdings after the transaction: 0

Dagsetning lokauppgjørs/Date of settlement: 17 May 2016

Athugasemdir/Comments: